Insider Transactions in Q2 2021 at Avantor, Inc. (AVTR)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
28,096
-20.33%
|
$983,360
$35.73 P/Share
|
|
Jun 25
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Direct |
68,605
-4.74%
|
$2,401,175
$35.32 P/Share
|
|
Jun 10
2021
|
Michael Stubblefield President & CEO |
SELL
Open market or private sale
|
Direct |
99,887
-3.43%
|
$3,196,384
$32.48 P/Share
|
|
Jun 10
2021
|
Michael Stubblefield President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
99,887
+3.32%
|
$299,661
$3.66 P/Share
|
|
Jun 09
2021
|
Michael Stubblefield President & CEO |
SELL
Open market or private sale
|
Direct |
235,170
-14.35%
|
$7,525,440
$32.03 P/Share
|
|
Jun 09
2021
|
Michael Stubblefield President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
235,170
+12.55%
|
$705,510
$3.13 P/Share
|
|
Jun 08
2021
|
Michael Stubblefield President & CEO |
SELL
Open market or private sale
|
Direct |
152,643
-9.81%
|
$4,884,576
$32.04 P/Share
|
|
Jun 08
2021
|
Michael Stubblefield President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
152,643
+8.93%
|
$457,929
$3.13 P/Share
|
|
May 27
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
100,000
-41.82%
|
$3,100,000
$31.99 P/Share
|
|
May 27
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+29.49%
|
$2,300,000
$23.21 P/Share
|
|
May 27
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Indirect |
78,109
-21.93%
|
$2,421,379
$31.94 P/Share
|
|
May 26
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Indirect |
150,000
-29.63%
|
$4,650,000
$31.89 P/Share
|
|
May 26
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
15,000
-9.73%
|
$465,000
$31.87 P/Share
|
|
May 26
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.87%
|
$345,000
$23.21 P/Share
|
|
May 24
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Indirect |
337,571
-22.54%
|
$10,464,701
$31.66 P/Share
|
|
May 24
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
9,124
-6.16%
|
$282,844
$31.75 P/Share
|
|
May 24
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
9,124
+5.8%
|
$155,108
$17.67 P/Share
|
|
May 21
2021
|
Michael Wondrasch EVP & CIO |
SELL
Open market or private sale
|
Direct |
18,488
-14.03%
|
$573,128
$31.41 P/Share
|
|
May 20
2021
|
Gerard Brophy EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct |
19,603
-11.6%
|
$607,693
$31.1 P/Share
|
|
May 20
2021
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
25,010
-15.33%
|
$775,310
$31.13 P/Share
|
|
May 20
2021
|
Justin Miller EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
18,488
-17.6%
|
$573,128
$31.12 P/Share
|
|
May 17
2021
|
Devashish Ohri EVP, IMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
16,793
-10.77%
|
$503,790
$30.9 P/Share
|
|
May 17
2021
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
14,276
-8.04%
|
-
|
|
May 17
2021
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
106,200
-7.04%
|
$3,186,000
$30.9 P/Share
|
|
May 17
2021
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
553
-1.72%
|
$16,590
$30.9 P/Share
|
|
May 17
2021
|
Michael Wondrasch EVP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,655
-9.39%
|
$409,650
$30.9 P/Share
|
|
May 17
2021
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,655
-11.51%
|
$409,650
$30.9 P/Share
|
|
May 17
2021
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,261
-8.53%
|
$697,830
$30.9 P/Share
|
|
May 17
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
14,324
-12.13%
|
$429,720
$30.9 P/Share
|
|
May 17
2021
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
2,210
-1.02%
|
$66,300
$30.9 P/Share
|
|
May 17
2021
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
19,683
-10.43%
|
$590,490
$30.9 P/Share
|
|
May 14
2021
|
Lan Kang Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,022
+50.0%
|
-
|
|
May 14
2021
|
Devashish Ohri EVP, IMEA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,000
-13.82%
|
$775,000
$31.5 P/Share
|
|
May 14
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+12.14%
|
$575,000
$23.21 P/Share
|
|
May 11
2021
|
Jo Natauri Director |
BUY
Other acquisition or disposition
|
Direct |
92,661
+50.0%
|
$2,779,830
$30.86 P/Share
|
|
May 11
2021
|
Jo Natauri Director |
SELL
Other acquisition or disposition
|
Indirect |
24,729,495
-99.29%
|
$741,884,850
$30.86 P/Share
|
|
May 11
2021
|
Jo Natauri Director |
SELL
Open market or private sale
|
Indirect |
2,626,771
-9.57%
|
$78,803,130
$30.68 P/Share
|
|
Apr 30
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
53,649
-25.6%
|
$1,716,768
$32.58 P/Share
|
|
Apr 30
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
53,649
+20.38%
|
$1,233,927
$23.21 P/Share
|
|
Apr 12
2021
|
Justin Miller EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
102,895
-24.06%
|
$3,292,640
$32.48 P/Share
|
|
Apr 12
2021
|
Justin Miller EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+31.38%
|
$2,300,000
$23.21 P/Share
|
|
Apr 12
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
2,505
-2.08%
|
$80,160
$32.0 P/Share
|
|
Apr 12
2021
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Open market or private sale
|
Direct |
27,075
-5.71%
|
$839,325
$31.79 P/Share
|
|
Apr 12
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
100,160
-39.12%
|
$3,205,120
$32.37 P/Share
|
|
Apr 12
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
100,160
+28.12%
|
$100,160
$1.6 P/Share
|
|
Apr 05
2021
|
Christophe Couturier EVP, AMEA |
BUY
Grant, award, or other acquisition
|
Direct |
8,267
+4.45%
|
-
|